<DOC>
	<DOCNO>NCT02793687</DOCNO>
	<brief_summary>A multicenter , prospective , randomize , double-blind , placebo-controlled , parallel group study patient stroke</brief_summary>
	<brief_title>Study Efficacy Safety MEXIDOL®</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Mexidol</mesh_term>
	<criteria>1 . Diagnosis : hemispheric ischemic stroke ( codes ICD10 : I63.0 I63.9 ) , primary . 2 . Patients sex , 40 80 year . 3 . Patients able understand purpose study observe requirement Protocol ; 4 . The time onset stroke 72 hour . 5 . Based Rankin Scale score 3 point time enrollment . 6 . Evaluation NIHSS scale 5 15 point . 7 . Based depression scale Beck &lt; 19 point 8 . Have personally sign date patient ( otherwise disinterested witness member research team direct subordinate principal investigator , absence physical possibility sign patient ) inform consent form . 9 . Have negative pregnancy test woman childbearing age . 10 . Consent use adequate contraception female patient / willingness use contraception female partner male patient abstinence sexual activity period study . 1 . Lack diagnosis : hemispheric ischemic stroke ( codes ICD10 : I63.0 I63.9 ) , primary . 2 . Age &lt; 40 &gt; 80 year . 3 . Assessment scale NIHSS &lt; 5 &gt; 15 point 4 . Hemorrhagic stroke ( confirmed imaging technique ( CT MRI ) . 5 . Hemorrhagic infarction ( ischemic stroke hemorrhagic impregnation ) . 6 . Repeated ischemic stroke . 7 . Parkinson 's disease . 8 . Epilepsy . 9 . Demyelinating disease nervous system . 10. hereditary degenerative disease CNS . 11 . The presence CNS infectious disease history . 12 . Traumatic brain injury severe neurological symptom cognitive disorder ( include history ) . 13 . Unstable angina pectoris . 14 . Myocardial infarction , prescription le 3 month . 15 . Chronic heart failure functional class IV accord classification New York Heart Association ( NYHA ) . 16. atrioventricular block degree IIIII . 17 . Systemic connective tissue disease . 18 . Chronic obstructive pulmonary stage IIIIV disease . 19 . Acute surgical pathology . 20 . Heavy , decompensated heart disease , liver , kidney , acute / chronic renal / hepatic failure . 21 . A history cancer , immunosuppressive condition , tuberculosis , drug alcohol addiction , mental illness . 22 . A history material , accord research physician , state , prevents inclusion study . 23 . Acute infectious disease ( influenza , SARS , etc . ) In less 4 week start study . 24 . Availability information lactose intolerance / congenital galactose intolerance ; Lapp lactase deficiency glucosegalactose syndrome malabsorption . 25 . Pregnancy , lactation . 26 . Mental , physical reason allow adequately assess behavior comply term protocol correctly . 27 . Patients employee research center , sponsor company , well family member . 28 . Participation clinical trial drug less 3 month prior study . 29 . Any condition circumstance make difficult , accord researcher , participate study . 30 . Individual intolerance emoxypine , well preparation contain salt succinic acid vitamin B6 history . 31 . The presence contraindication use drug MEXIDOL® 32 . No personally sign date patient ( otherwise disinterested witness absence physical possibility sign patient ) inform consent form .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>